See F - Search Results

1

Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.

Kasikis S, Baez J, Gandhi I, Grupp S, Kitko CL, Kowalyk S, Merli P, Morales G, Pulsipher MA, Qayed M, Wölfl M, Yanik G, See F, Hayes J, Grossman F, Burke E, Young R, Levine JE, Ferrara JLM. Kasikis S, et al. Among authors: see f. Bone Marrow Transplant. 2021 Nov;56(11):2869-2870. doi: 10.1038/s41409-021-01442-3. Epub 2021 Sep 1. Bone Marrow Transplant. 2021. PMID: 34471240 Free PMC article. No abstract available.

2

Islet grafting and imaging in a bioengineered intramuscular space.

Witkowski P, Sondermeijer H, Hardy MA, Woodland DC, Lee K, Bhagat G, Witkowski K, See F, Rana A, Maffei A, Itescu S, Harris PE. Witkowski P, et al. Among authors: see f. Transplantation. 2009 Nov 15;88(9):1065-74. doi: 10.1097/TP.0b013e3181ba2e87. Transplantation. 2009. PMID: 19898201 Free PMC article.

3

A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.

Witkowski P, Seki T, Xiang G, Martens T, Sondermeijer H, See F, Bhagat G, Schuster M, Hardy MA, Itescu S. Witkowski P, et al. Among authors: see f. J Cardiovasc Pharmacol. 2007 Dec;50(6):633-40. doi: 10.1097/FJC.0b013e318150d6b3. J Cardiovasc Pharmacol. 2007. PMID: 18091579

4

Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia.

Xiang G, Seki T, Schuster MD, Witkowski P, Boyle AJ, See F, Martens TP, Kocher A, Sondermeijer H, Krum H, Itescu S. Xiang G, et al. Among authors: see f. J Biol Chem. 2005 Nov 25;280(47):39394-402. doi: 10.1074/jbc.M502966200. Epub 2005 Sep 19. J Biol Chem. 2005. PMID: 16172122 Free article.

5

Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium.

Martens TP, See F, Schuster MD, Sondermeijer HP, Hefti MM, Zannettino A, Gronthos S, Seki T, Itescu S. Martens TP, et al. Among authors: see f. Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S18-22. doi: 10.1038/ncpcardio0404. Nat Clin Pract Cardiovasc Med. 2006. PMID: 16501624

6

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia.

See F, Seki T, Psaltis PJ, Sondermeijer HP, Gronthos S, Zannettino AC, Govaert KM, Schuster MD, Kurlansky PA, Kelly DJ, Krum H, Itescu S. See F, et al. J Cell Mol Med. 2011 Oct;15(10):2117-29. doi: 10.1111/j.1582-4934.2010.01241.x. J Cell Mol Med. 2011. PMID: 21155976 Free PMC article.

7

p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.

See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H. See F, et al. J Am Coll Cardiol. 2004 Oct 19;44(8):1679-89. doi: 10.1016/j.jacc.2004.07.038. J Am Coll Cardiol. 2004. PMID: 15489104 Free article.

8

Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.

Psaltis PJ, Paton S, See F, Arthur A, Martin S, Itescu S, Worthley SG, Gronthos S, Zannettino AC. Psaltis PJ, et al. Among authors: see f. J Cell Physiol. 2010 May;223(2):530-40. doi: 10.1002/jcp.22081. J Cell Physiol. 2010. PMID: 20162565

9

Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: possible role of transforming growth factor beta(1).

Tzanidis A, Lim S, Hannan RD, See F, Ugoni AM, Krum H. Tzanidis A, et al. Among authors: see f. J Mol Cell Cardiol. 2001 May;33(5):969-81. doi: 10.1006/jmcc.2001.1361. J Mol Cell Cardiol. 2001. PMID: 11343419

A. Tzanidis, S. Lim, R. D. Hannan, F. See, A. M. Ugoni and H. Krum. Combined Angiotensin and Endothelin Receptor Blockade Attenuates Adverse Cardiac Remodeling Post-Myocardial Infarction in the Rat: Possible Role of Transforming Growth Factor beta(1). ...

A. Tzanidis, S. Lim, R. D. Hannan, F. See, A. M. Ugoni and H. Krum. Combined Angiotensin and Endothelin Receptor Blockade Atte …

10

Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.

Kompa AR, See F, Lewis DA, Adrahtas A, Cantwell DM, Wang BH, Krum H. Kompa AR, et al. Among authors: see f. J Pharmacol Exp Ther. 2008 Jun;325(3):741-50. doi: 10.1124/jpet.107.133546. Epub 2008 Mar 11. J Pharmacol Exp Ther. 2008. PMID: 18334667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters